![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Akinbiyi A. A. (1996) Unexplained elevated maternal serum alpha-fetoprotein in singleton pregnancies as a predictor of fetal risk. International Journal of Gynaecology and Obste-trics, 53, 17–21.
- CARIS Annual Report (1999) Down Syndrome Update, 20— 22. Dawson A., Jones G., Mathora M. and Reynolds T. (1992)
- Serum screening for Downs syndrome; one year's experience in South Wales. Report to the Welsh Office.
- Fairgrieve S. (1997) Screening for Down syndrome: what the women think. British Journal of Midwifery, 5, 148— 151.
- Gilbert R. E., Augood C., Gupta R., Ades A. E., Logan S., Sculpher M. and van der Meulen J. H. P. (2001) Screening for Down syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. British Medical Journal, 323, 423–425.
- Green J. M., Statham H. and Snowdon C. (1993) Women's knowledge of prenatal screening tests 1: relationships with hospital screening policy and demographic factors. Journal of Reproductive and Infant Psychology, 11, 11— 20.
- Green J. M. (1994) Serum screening for Downs syndrome: experiences of obstetricians in England and Wales. British Medical Journal, 309, 769–772.
- Grewal G. K., Moss H. J., Aitken D. A., Bjornsson S., Cameron A. D. and Pell J. P. (1997) Factors affecting women's knowledge of antenatal serum screening. Scottish Medical Journal, 42, 111–113.
- Royal College of Obstetricians and Gynaecologists (RCOG) (1993) Report of the RCOG Working Party on Biochemical Markers and the Detection of Downs Syndrome. London, RCOG Press.
- Smith D. K., Shaw R. W. and Marteau T. M. (1994) Informed consent to undergo serum screening for Downs syndrome: the gap between policy and practice. British Medical Journal, 309, 776.
- Thase M., Liss L., Smeltzer D. and Maloon J. (1982) Clinical evaluation of dementia in Down syndrome: a preliminary report. Journal of Mental Deficiency Research, 26, 239–244.
- Van Rijn M., van der Schouw Y. T., Hagenaars A. M., Visser G. H. and Christiaens G. C. (1999) Adverse obstetric outcome in low- and high-risk pregnancies: predictive value of maternal serum screening. Obstetrics and Gynecology, 94, 929–934.
- Vyas S. (1994) Screening for Downs syndrome. British Medical Journal, 309, 753 — 754.
- Wald N. J., Cuckle H. S., Densem J. W., Kennard A. and Smith D. (1992) Maternal serum screening for Downs syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. British Journal of Obstetrics and Gynaecology, 99, 144 — 149.
- Wald N. J., Kennard A., Hackshaw A. and McGuire A. (1997) Antenatal screening for Down syndrome. Journal of Medical Screening, 4, 181— 246.
- Wald N. and Leck I. (2000) The screening test. In: Antenatal and neonatal screening, edited by Wald N. and Leck I., 2nd edn, chapter 1, pp. 7–16. Oxford, Oxford University Press.
- Waldenstrom U., Axelsson O. and Nilsson S. (1991) Sono-graphic dating of pregnancies among women with menstrual irregularities. Acta Obstetricia et Gynecologica Scandinavica, 70, 17–20.
- Whittle M. (2001) Down syndrome screening: where to now? British Journal of Obstetrics and Gynaecology, 108, 559 — 561.